Indonesia to resume use of AstraZeneca vaccine after reviewing blood clot concerns

Indonesia to resume use of AstraZeneca vaccine after reviewing blood clot concerns
Indonesia to resume use of AstraZeneca vaccine after reviewing blood clot concerns

Hello and welcome to the details of Indonesia to resume use of AstraZeneca vaccine after reviewing blood clot concerns and now with the details

Nevin Al Sukari - Sana'a - Vials with a sticker reading, ‘Covid-19 / Coronavirus vaccine / Injection only’ and a medical syringe are seen in front of a displayed AstraZeneca logo in this illustration taken October 31, 2020. ― Reuters pic

Subscribe to our Telegram channel for the latest updates on news you need to know.


JAKARTA, March 19 — Indonesia’s Food and Drug agency (BPOM) said today it has approved the usage of AstraZeneca’s Covid-19 vaccine after reviewing reports the vaccine had caused blood clots among some recipients in Europe.

In a statement, the agency said that even though vaccination could lead to “adverse events” following immunisation, “the risk of death from Covid-19 is much higher.”

“The benefits of giving the AstraZeneca Covid-19 vaccine outweigh the risks,” the agency said.

BPOM did caution against the use of the AstraZeneca vaccine for people with a low blood platelet count, known as thrombocytopenia, and blood clotting disorders.

Indonesia had previously delayed administering the AstraZeneca vaccine following the blood clot reports, saying it was awaiting the results of a review by the World Health Organization (WHO).

The European Medicines Agency said this week there were no indication the events were caused by the vaccination, a view echoed by the WHO. AstraZeneca also said its review had shown no evidence of an increased risk of blood clots.

Indonesia has been grappling with one of the worst coronavirus outbreaks in Asia – with 1,437,283 cases and 38,915 deaths.

The South-east Asian nation kicked off its vaccine programme this January, after receiving its first shipment of the CoronaVac vaccine produced by China’s Sinovac Biotech.

Indonesia received 1.1 million doses of the AstraZeneca vaccine via the COVAX vaccine-alliance scheme this month and is set to receive some 10 million more in the next two months. — Reuters

These were the details of the news Indonesia to resume use of AstraZeneca vaccine after reviewing blood clot concerns for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.

It is also worth noting that the original news has been published and is available at Malay Mail and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.

PREV Abu Dhabi art gallery owner has a sideline business: trading COVID-19 vaccines
NEXT Youth join mainstream as India unveils development initiatives in Jammu and Kashmir